ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10AE54 | BioTech | Insulin glargine - 100IU/ml, Lixisenatide - 33mcg/ml | 10559 | 160420/1 | SULIQUA | 3x3ml | Injectable solution | SC | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 7,975,793 L.L | 21.26 | C | Sanofi Aventis (Suisse) SA | Switzerland | 2/5/2024 | 0 |